Latest Insider Transactions at Amgen Inc (AMGN)
This section provides a real-time view of insider transactions for Amgen Inc (AMGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2022
|
Derek Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-4.95%
|
$67,977
$249.87 P/Share
|
|
Apr 27
2022
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.38%
|
$45,816
$249.87 P/Share
|
|
Apr 27
2022
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
599
-1.07%
|
$149,151
$249.87 P/Share
|
|
Mar 18
2022
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
17,481
-2.77%
|
$4,108,035
$235.86 P/Share
|
|
Mar 18
2022
|
Murdo Gordon EVP, Global Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
4,995
-10.02%
|
$1,173,825
$235.86 P/Share
|
|
Mar 18
2022
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,496
-6.63%
|
$821,560
$235.86 P/Share
|
|
Mar 18
2022
|
Nancy A. Grygiel SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
350
-2.37%
|
$82,250
$235.86 P/Share
|
|
Mar 18
2022
|
Rachna Khosla SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
322
-4.49%
|
$75,670
$235.86 P/Share
|
|
Mar 18
2022
|
Linda H. Louie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-1.18%
|
$25,380
$235.86 P/Share
|
|
Mar 18
2022
|
Derek Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-5.6%
|
$76,845
$235.86 P/Share
|
|
Mar 18
2022
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,995
-9.44%
|
$1,173,825
$235.86 P/Share
|
|
Mar 18
2022
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
4,370
-7.25%
|
$1,026,950
$235.86 P/Share
|
|
Mar 01
2022
|
Robert A Bradway Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
34,964
+5.26%
|
-
|
|
Mar 01
2022
|
Murdo Gordon EVP, Global Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
9,989
+16.74%
|
-
|
|
Mar 01
2022
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
6,992
+11.76%
|
-
|
|
Mar 01
2022
|
Nancy A. Grygiel SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,001
+6.4%
|
-
|
|
Mar 01
2022
|
Rachna Khosla SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
923
+11.45%
|
-
|
|
Mar 01
2022
|
Linda H. Louie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
436
+4.57%
|
-
|
|
Mar 01
2022
|
Lori A Johnston EVP, HR |
BUY
Grant, award, or other acquisition
|
Direct |
4,495
+9.91%
|
-
|
|
Mar 01
2022
|
David M Reese EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,989
+15.93%
|
-
|
|
Mar 01
2022
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,740
+12.69%
|
-
|
|
Nov 05
2021
|
Nancy A. Grygiel SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
935
+6.46%
|
-
|
|
Nov 05
2021
|
Rachna Khosla SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
2,104
+15.67%
|
-
|
|
Nov 05
2021
|
Linda H. Louie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
350
+3.89%
|
-
|
|
Nov 05
2021
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
187
+3.17%
|
-
|
|
Nov 05
2021
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+1.76%
|
-
|
|
Nov 02
2021
|
Murdo Gordon EVP, Global Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
5,585
-12.36%
|
$1,167,265
$209.79 P/Share
|
|
Nov 02
2021
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,192
-4.89%
|
$458,128
$209.74 P/Share
|
|
Nov 01
2021
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,591
-3.39%
|
$327,746
$206.97 P/Share
|
|
Nov 01
2021
|
Peter H. Griffith EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,661
-10.09%
|
$548,166
$206.97 P/Share
|
|
Nov 01
2021
|
Lori A Johnston EVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-3.59%
|
$278,512
$206.97 P/Share
|
|
Aug 06
2021
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
347
+5.96%
|
-
|
|
Aug 06
2021
|
Omar Ishrak Director |
BUY
Grant, award, or other acquisition
|
Direct |
760
+44.84%
|
-
|
|
Aug 06
2021
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
282
+3.3%
|
-
|
|
May 18
2021
|
Brian Druker Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+18.72%
|
-
|
|
May 18
2021
|
Wanda M Austin Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+17.19%
|
-
|
|
May 18
2021
|
Robert Eckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+5.96%
|
-
|
|
May 18
2021
|
Greg C. Garland Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+7.82%
|
-
|
|
May 18
2021
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+14.11%
|
-
|
|
May 18
2021
|
Tyler Jacks Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+6.32%
|
-
|
|
May 18
2021
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+9.55%
|
-
|
|
May 18
2021
|
Amy E Miles Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+40.2%
|
-
|
|
May 18
2021
|
Ronald D Sugar Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+4.76%
|
-
|
|
May 18
2021
|
R Sanders Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
837
+13.76%
|
-
|
|
May 12
2021
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
1,000
-5.91%
|
$250,000
$250.59 P/Share
|
|
May 12
2021
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.58%
|
$71,000
$71.64 P/Share
|
|
May 11
2021
|
Nancy A. Grygiel SVP & CCO |
SELL
Open market or private sale
|
Direct |
2,500
-16.71%
|
$630,000
$252.51 P/Share
|
|
May 11
2021
|
Nancy A. Grygiel SVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+14.32%
|
$405,000
$162.6 P/Share
|
|
May 07
2021
|
R Sanders Williams Director |
SELL
Open market or private sale
|
Direct |
250
-5.37%
|
$62,750
$251.78 P/Share
|
|
May 03
2021
|
Murdo Gordon EVP, Global Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
782
-1.71%
|
$186,898
$239.64 P/Share
|